These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1577053)

  • 1. Pharmacokinetics of midazolam during continuous infusion in critically ill neonates.
    Jacqz-Aigrain E; Daoud P; Burtin P; Maherzi S; Beaufils F
    Eur J Clin Pharmacol; 1992; 42(3):329-32. PubMed ID: 1577053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of midazolam in critically ill neonates.
    Jacqz-Aigrain E; Wood C; Robieux I
    Eur J Clin Pharmacol; 1990; 39(2):191-2. PubMed ID: 2253674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of midazolam in neonates.
    Burtin P; Jacqz-Aigrain E; Girard P; Lenclen R; Magny JF; Betremieux P; Tehiry C; Desplanques L; Mussat P
    Clin Pharmacol Ther; 1994 Dec; 56(6 Pt 1):615-25. PubMed ID: 7995003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.
    Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
    Br J Clin Pharmacol; 2004 Feb; 57(2):135-45. PubMed ID: 14748812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit.
    Ng E; Taddio A; Ohlsson A
    Cochrane Database Syst Rev; 2000; (2):CD002052. PubMed ID: 10796280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients.
    Malacrida R; Fritz ME; Suter PM; Crevoisier C
    Crit Care Med; 1992 Aug; 20(8):1123-6. PubMed ID: 1643892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of midazolam in critically ill pediatric patients.
    Nahara MC; McMorrow J; Jones PR; Anglin D; Rosenberg R
    Eur J Drug Metab Pharmacokinet; 2000; 25(3-4):219-21. PubMed ID: 11420893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midazolam infusion for basal sedation in intensive care: absence of accumulation.
    Michalk S; Moncorge C; Fichelle A; Huot O; Servin F; Farinotti R; Desmonts JM
    Intensive Care Med; 1988; 15(1):37-41. PubMed ID: 3230199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of long-term infusion of midazolam in critically ill patients--preliminary results.
    Dirksen MS; Vree TB; Driessen JJ
    Anaesth Intensive Care; 1987 Nov; 15(4):440-4. PubMed ID: 3122596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing sedation following major vascular surgery: a double-blind study of midazolam administered by continuous infusion.
    Miller DR; Martineau RJ; Hull KA; Vallée F; LeBel M
    Can J Anaesth; 1994 Sep; 41(9):782-93. PubMed ID: 7954994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetic modeling in very premature infants receiving midazolam during mechanical ventilation: midazolam neonatal pharmacokinetics.
    Lee TC; Charles BG; Harte GJ; Gray PH; Steer PA; Flenady VJ
    Anesthesiology; 1999 Feb; 90(2):451-7. PubMed ID: 9952152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of continuous infusions of fentanyl in critically ill children.
    Katz R; Kelly HW
    Crit Care Med; 1993 Jul; 21(7):995-1000. PubMed ID: 8319480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit.
    Barr J; Donner A
    Crit Care Clin; 1995 Oct; 11(4):827-47. PubMed ID: 8535981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Propofol versus midazolam. Long-term sedation in the intensive care unit].
    Beyer R; Seyde WC
    Anaesthesist; 1992 Jun; 41(6):335-41. PubMed ID: 1636917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of long-term sufentanil infusion for sedation in ICU patients.
    Ethuin F; Boudaoud S; Leblanc I; Troje C; Marie O; Levron JC; Le Moing JP; Assoune P; Eurin B; Jacob L
    Intensive Care Med; 2003 Nov; 29(11):1916-20. PubMed ID: 12923616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacodynamic modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients.
    Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
    Eur J Clin Pharmacol; 2006 Mar; 62(3):185-94. PubMed ID: 16425056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model.
    Barr J; Zomorodi K; Bertaccini EJ; Shafer SL; Geller E
    Anesthesiology; 2001 Aug; 95(2):286-98. PubMed ID: 11506097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical illness is a major determinant of midazolam clearance in children aged 1 month to 17 years.
    Ince I; de Wildt SN; Peeters MY; Murry DJ; Tibboel D; Danhof M; Knibbe CA
    Ther Drug Monit; 2012 Aug; 34(4):381-9. PubMed ID: 22660604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of prolonged dexmedetomidine use in critically ill children with heart disease*.
    Gupta P; Whiteside W; Sabati A; Tesoro TM; Gossett JM; Tobias JD; Roth SJ
    Pediatr Crit Care Med; 2012 Nov; 13(6):660-6. PubMed ID: 22791093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Midazolam for anesthetic induction in neonates].
    Kawakami K; Ohata J; Kadosaki M; Saito I; Iwasawa K; Mitono H
    Masui; 1998 May; 47(5):570-5. PubMed ID: 9621667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.